This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics. This report contains market size and forecasts of Prostate Cancer Therapeutics in global, including the following market information:
Global Prostate Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Therapeutics market was valued at US$ 7634.8 million in 2022 and is projected to reach US$ 9829 million by 2029, at a CAGR of 3.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Therapeutics include Sanofi, Pfizer, Amgen, Johnson & Johnson, AstraZeneca, AbbVie, Bayer, Ipsen Group and Endo Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Drugs
Medical Devices
Global Prostate Cancer Therapeutics Market, by Sale Channel, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Therapeutics Market Segment Percentages, by Sale Channel, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Sales
Global Prostate Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Pfizer
Amgen
Johnson & Johnson
AstraZeneca
AbbVie
Bayer
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation(Sanpower Group Co. Ltd.)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Therapeutics, market overview.
Chapter 2: Global Prostate Cancer Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sale channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sale Channel
1.3 Global Prostate Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Therapeutics Overall Market Size
2.1 Global Prostate Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Prostate Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Therapeutics Players in Global Market
3.2 Top Global Prostate Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Prostate Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Drugs
4.1.3 Medical Devices
4.2 By Type - Global Prostate Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
5 Sights by Sale Channel
5.1 Overview
5.1.1 By Sale Channel - Global Prostate Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Sales
5.2 By Sale Channel - Global Prostate Cancer Therapeutics Revenue & Forecasts
5.2.1 By Sale Channel - Global Prostate Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Sale Channel - Global Prostate Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Sale Channel - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Prostate Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Prostate Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Prostate Cancer Therapeutics Revenue, 2018-2029
6.3.2 US Prostate Cancer Therapeutics Market Size, 2018-2029
6.3.3 Canada Prostate Cancer Therapeutics Market Size, 2018-2029
6.3.4 Mexico Prostate Cancer Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Therapeutics Revenue, 2018-2029
6.4.2 Germany Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.3 France Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.4 U.K. Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.5 Italy Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.6 Russia Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Prostate Cancer Therapeutics Market Size, 2018-2029
6.4.8 Benelux Prostate Cancer Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Therapeutics Revenue, 2018-2029
6.5.2 China Prostate Cancer Therapeutics Market Size, 2018-2029
6.5.3 Japan Prostate Cancer Therapeutics Market Size, 2018-2029
6.5.4 South Korea Prostate Cancer Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Prostate Cancer Therapeutics Market Size, 2018-2029
6.5.6 India Prostate Cancer Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Prostate Cancer Therapeutics Revenue, 2018-2029
6.6.2 Brazil Prostate Cancer Therapeutics Market Size, 2018-2029
6.6.3 Argentina Prostate Cancer Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, 2018-2029
6.7.2 Turkey Prostate Cancer Therapeutics Market Size, 2018-2029
6.7.3 Israel Prostate Cancer Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Prostate Cancer Therapeutics Market Size, 2018-2029
6.7.5 UAE Prostate Cancer Therapeutics Market Size, 2018-2029
7 Prostate Cancer Therapeutics Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Prostate Cancer Therapeutics Major Product Offerings
7.1.4 Sanofi Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Prostate Cancer Therapeutics Major Product Offerings
7.2.4 Pfizer Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Prostate Cancer Therapeutics Major Product Offerings
7.3.4 Amgen Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Therapeutics Major Product Offerings
7.4.4 Johnson & Johnson Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Prostate Cancer Therapeutics Major Product Offerings
7.5.4 AstraZeneca Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Prostate Cancer Therapeutics Major Product Offerings
7.6.4 AbbVie Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Prostate Cancer Therapeutics Major Product Offerings
7.7.4 Bayer Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Ipsen Group
7.8.1 Ipsen Group Company Summary
7.8.2 Ipsen Group Business Overview
7.8.3 Ipsen Group Prostate Cancer Therapeutics Major Product Offerings
7.8.4 Ipsen Group Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Ipsen Group Key News & Latest Developments
7.9 Endo Pharmaceuticals
7.9.1 Endo Pharmaceuticals Company Summary
7.9.2 Endo Pharmaceuticals Business Overview
7.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Major Product Offerings
7.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Endo Pharmaceuticals Key News & Latest Developments
7.10 Dendreon Corporation(Sanpower Group Co. Ltd.)
7.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Company Summary
7.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview
7.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Major Product Offerings
7.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Therapeutics Market Drivers in Global Market
Table 3. Prostate Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Therapeutics in Global Market
Table 5. Top Prostate Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Prostate Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Sale Channel ? Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Sale Channel - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Sale Channel - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Prostate Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Prostate Cancer Therapeutics Product Offerings
Table 32. Sanofi Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Prostate Cancer Therapeutics Product Offerings
Table 36. Pfizer Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Prostate Cancer Therapeutics Product Offerings
Table 40. Amgen Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Prostate Cancer Therapeutics Product Offerings
Table 44. Johnson & Johnson Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Prostate Cancer Therapeutics Product Offerings
Table 48. AstraZeneca Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Prostate Cancer Therapeutics Product Offerings
Table 52. AbbVie Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Prostate Cancer Therapeutics Product Offerings
Table 56. Bayer Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Ipsen Group Company Summary
Table 59. Ipsen Group Prostate Cancer Therapeutics Product Offerings
Table 60. Ipsen Group Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Ipsen Group Key News & Latest Developments
Table 62. Endo Pharmaceuticals Company Summary
Table 63. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Offerings
Table 64. Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Endo Pharmaceuticals Key News & Latest Developments
Table 66. Dendreon Corporation(Sanpower Group Co. Ltd.) Company Summary
Table 67. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Offerings
Table 68. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Dendreon Corporation(Sanpower Group Co. Ltd.) Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Therapeutics Segment by Type in 2022
Figure 2. Prostate Cancer Therapeutics Segment by Sale Channel in 2022
Figure 3. Global Prostate Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prostate Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Sale Channel - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Sale Channel - Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Sale Channel - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Prostate Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AstraZeneca Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Ipsen Group Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
